Sabra Health Care REIT (SBRA) Cash from Financing Activities (2011 - 2026)

Sabra Health Care REIT's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $52.1 million for Q1 2026.

• On a quarterly basis, Cash from Financing Activities rose 151.46% year-over-year to $52.1 million in Q1 2026; TTM through Mar 2026 was $194.1 million, a 173.92% increase from a year earlier, with the FY2025 full-year figure at $40.8 million, up 122.45% from the prior year.
• Cash from Financing Activities climbed to $52.1 million in Q1 2026 per SBRA's latest filing, from -$100.9 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $206.2 million in Q3 2025 and bottomed at -$196.1 million in Q1 2023.
• The 5-year median for Cash from Financing Activities is -$46.4 million (2024), against an average of -$38.9 million.
• Across the five-year window, Cash from Financing Activities jumped 2164.31% in 2022 and plunged 978.33% in 2024, its largest moves.
• Year by year, Cash from Financing Activities stood at -$13.5 million in 2022, then soared by 30.74% to -$9.4 million in 2023, then plunged by 978.33% to -$101.0 million in 2024, then grew by 0.07% to -$100.9 million in 2025, then surged by 151.64% to $52.1 million in 2026.
• Per Business Quant, the three latest SBRA Cash from Financing Activities figures stand at $52.1 million (Q1 2026), -$100.9 million (Q4 2025), and $206.2 million (Q3 2025).